HRA000458
Title:
Establishment of criteria for molecular differential diagnosis of MPLC and IPM
Release date:
2020-11-28
Description:
Differential diagnosis of multiple primary lung cancer (MPLC) and intrapulmonary metastasis (IPM) is one difficulty in lung cancer diagnosis, and crucial for establishment of treatment strategies and prognosis prediction. This study aims to establish the criteria for molecular differential diagnosis of synchronous MPLC and IPM by the next-generation sequencing (NGS)method.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
lung cancer
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
HaploX
Contact person:
chen shifu
Email:
chen@haplox.com
Description:
molecular dignostic
Individuals & samples
Submitter:   Chen Shifu / chen@haplox.com
Organization:   HaploX Biotechnology Co., Ltd
Submission date:   2020-11-19
Requests:   -